A detailed history of Morgan Stanley transactions in Haleon PLC stock. As of the latest transaction made, Morgan Stanley holds 8,237,797 shares of HLN stock, worth $77.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,237,797
Previous 7,198,755 14.43%
Holding current value
$77.4 Million
Previous $59.5 Million 46.58%
% of portfolio
0.01%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.32 - $10.7 $8.64 Million - $11.1 Million
1,039,042 Added 14.43%
8,237,797 $87.2 Million
Q2 2024

Oct 17, 2024

BUY
$8.01 - $8.64 $2.09 Million - $2.25 Million
260,451 Added 3.75%
7,198,755 $59.5 Million
Q2 2024

Aug 14, 2024

BUY
$8.01 - $8.64 $2.09 Million - $2.25 Million
260,451 Added 3.75%
7,198,755 $59.5 Million
Q1 2024

Oct 17, 2024

SELL
$8.02 - $8.67 $2.09 Million - $2.26 Million
-260,451 Reduced 3.62%
6,938,304 $58.9 Million
Q1 2024

Aug 16, 2024

BUY
$8.02 - $8.67 $3.77 Million - $4.07 Million
469,597 Added 7.26%
6,938,304 $58.9 Million
Q1 2024

May 15, 2024

BUY
$8.02 - $8.67 $3.77 Million - $4.07 Million
469,597 Added 7.26%
6,938,304 $58.9 Million
Q4 2023

Aug 16, 2024

SELL
$7.78 - $8.62 $5.68 Million - $6.29 Million
-730,048 Reduced 10.14%
6,468,707 $53.2 Million
Q4 2023

Feb 13, 2024

BUY
$7.78 - $8.62 $2.02 Million - $2.23 Million
259,254 Added 4.18%
6,468,707 $53.2 Million
Q3 2023

Nov 15, 2023

BUY
$7.85 - $8.94 $276,838 - $315,278
35,266 Added 0.57%
6,209,453 $51.7 Million
Q2 2023

Aug 14, 2023

SELL
$8.04 - $9.0 $2.46 Million - $2.75 Million
-305,863 Reduced 4.72%
6,174,187 $51.7 Million
Q1 2023

May 15, 2023

SELL
$7.57 - $8.37 $8.23 Million - $9.1 Million
-1,087,787 Reduced 14.37%
6,480,050 $52.7 Million
Q4 2022

Feb 14, 2023

BUY
$5.96 - $8.06 $15 Million - $20.2 Million
2,509,301 Added 49.61%
7,567,837 $60.5 Million
Q3 2022

Nov 14, 2022

BUY
$5.63 - $7.5 $28.5 Million - $37.9 Million
5,058,536 New
5,058,536 $30.8 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.